Physician

Dennis Slavin, M.D.

According to 2025 Medicare claims, Dennis Slavin, M.D. (NPI: 1215968995) practices anesthesiology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is DENNIS SLAVIN PA (NPI: 1881850535) and primary practice location at 78596-4346.

Slavin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 535 traditional Medicare patients, billed 9,653 HCPCS/CPT codes, and received $414,337 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 10,788 prescription claims across 1,308 beneficiaries totaling $360,289 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 25 records totaling $443. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $284,159 to $360,289. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$300K$600K2015 Medicare payment: $409,354 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $465,827 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $471,962 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $469,395 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $527,448 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $460,508 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $599,895 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $510,235 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $474,646 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $414,337 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201586811,748$409,354
201685915,576$465,827
201779615,641$471,962
201876313,136$469,395
201977416,816$527,448
202069415,772$460,508
202176317,149$599,895
202269612,243$510,235
202362311,129$474,646
20245359,653$414,337

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$298K$596K2015 Drug cost: $284,159 (USD; Tot_Drug_Cst)2016 Drug cost: $307,755 (USD; Tot_Drug_Cst)2017 Drug cost: $354,396 (USD; Tot_Drug_Cst)2018 Drug cost: $349,165 (USD; Tot_Drug_Cst)2019 Drug cost: $356,262 (USD; Tot_Drug_Cst)2020 Drug cost: $303,341 (USD; Tot_Drug_Cst)2021 Drug cost: $383,571 (USD; Tot_Drug_Cst)2022 Drug cost: $574,992 (USD; Tot_Drug_Cst)2023 Drug cost: $595,851 (USD; Tot_Drug_Cst)2024 Drug cost: $360,289 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157373,940$284,159
20168314,840$307,755
20177695,426$354,396
20187716,037$349,165
20198767,015$356,262
20209337,864$303,341
20211,1359,188$383,571
20221,21411,121$574,992
20231,31511,117$595,851
20241,30810,788$360,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
62323Injection of substance into lower spine canal using imaging guidance202267$179
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3491,476$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more246676$62
80305Testing for presence of drug, read by direct observation350666$12
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg3362,692$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen3,758102,926$83,383
FentanylFentanyl2246,658$35,458
MovantikNaloxegol Oxalate852,654$34,358
Nucynta ErTapentadol Hcl12360$21,587
Oxycodone HclOxycodone Hcl64518,157$17,911

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$443Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Dennis Slavin, M.D.?

Tedicare shows public-source Medicare data for Dennis Slavin, M.D. (NPI 1215968995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dennis Slavin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dennis Slavin, M.D.?

Dennis Slavin, M.D. is linked to DENNIS SLAVIN PA (billing NPI 1881850535) in the available physician profile data.

Does Dennis Slavin, M.D. have Open Payments data?

Dennis Slavin, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.